Michael Maline, DO
Orthopaedic Surgery · Oklahoma City, OKNPI 1801075759
Payments from drug & device makers
Across 64 payments — averaging $88.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$3K
- Medacta USA, Inc.$1K
- Stryker$451
- Sanofi-aventis U.S. LLC$126
- Bioventus LLC$120
- Pacira Therapeutics, Inc.$118
- plus $516 from 11 others
What the payments were for
- Travel & lodging$3,34359%
- Food & beverage$2,32741%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 8 | $3,184 |
| Medacta USA, Inc. | 7 | $1,156 |
| Stryker | 9 | $451 |
| Sanofi-aventis U.S. LLC | 6 | $126 |
| Bioventus LLC | 7 | $120 |
| Pacira Therapeutics, Inc. | 5 | $118 |
| Smith+Nephew | 1 | $98 |
| Kowa Pharmaceuticals America, Inc. | 5 | $76 |
| Amgen | 4 | $73 |
| Heron Therapeutics, Inc. | 1 | $66 |
| Avanos Medical | 3 | $62 |
| DJO, LLC | 2 | $43 |
| Solventum Corporation | 1 | $24 |
| Dynasplint Systems Inc. | 1 | $21 |
| Baudax Bio Inc. | 1 | $20 |
| Sonex Health, Inc. | 2 | $18 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Persona$1,158
- AMISTEM$981
- GMK SPHERE$333
- TRIATHLON$163
- ACCOLADE$109
- LFIT$109
How this compares
$5,670 in reported general payments places this provider in the 55th percentile of 263 orthopaedic surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 16 | $1,070 |
| Ondansetron OdtOndansetron | 69 | $451 |
| Oxycodone Hcl | 74 | $398 |
| Ibuprofen | 53 | $249 |
| Tizanidine Hcl | 80 | $236 |
| Methylprednisolone | 26 | $210 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $183 |
| Tramadol Hcl | 31 | $74 |
| Meloxicam | 19 | $61 |
| Diclofenac Sodium | 11 | $61 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Oklahoma City
- Andrew ParkinsonOklahoma City$3.1M
- Carlan YatesOklahoma City$772K
- Bradley ReddickOklahoma City$573K
- Jason EmersonOklahoma City$189K
- Paul MaitinoOklahoma City$176K
- Ronald DumiganOklahoma City$169K
- Michael JohnsonOklahoma City$133K
- Thomas TkachOklahoma City$84K
- Brian LevingsOklahoma City$80K
- Christopher WhiteOklahoma City$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.